InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions
Stock Information for InspireMD Inc.
Loading
Please wait while we load your information from QuoteMedia.